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INTRODUCTION
Malignant peripheral nerve sheath tumours (MPNST)
are rare soft tissue sarcomas of ectomesenchymal
origin. They are considered highly malignant sarcomas
which are locally invasive, associated with high rates of
recurrences and metastatic spread.1 This tumour is
usually seen in lower extremities and retroperitoneal
region and is rare in the head and neck region. The
World Health Organization coined the term MPNST to
substitute the previously heterogeneous and often
confusing terms, such as malignant schwannoma,
malignant neurilemmoma, neurogenic sarcoma, and
neurofibrosarcoma. Cases of MPNSTs have been
reported mostly in the soft tissues, less common in the
bones and very rare in the maxilla.2,3 We report a case
of MPNST in a 50 years old male with a right maxillary
mass.
CASE REPORT
A 50-year-old male patient complained of swelling on
the right side of face since 4 months. He gave a history
of swelling, which was initially small, roughly marble
sized and progressively increased in size over the past
four months. It was not associated with any dental pain.
There was no fluctuation in the size of the swelling.
Patient also did not have any history of epistaxis,
speech, chewing or breathing difficulty, numbness over
the face or blurring of vision. Past medical, dental and
surgical histories were insignificant. His personal history
revealed that he was a chronic tobacco chewer and
smoker.
Extra oral examination showed an ovoid swelling
measuring 6x5 cm on the right middle third of face just
below the eye. The skin over the swelling was stretched
and surrounding tissue appeared normal. This swelling
was firm, non-compressible, nonfluctuant and non-
reducible. Upon intra oral examination no visible ulcer or
swelling or loose teeth identified. Mouth opening was
adequate. Nasal endoscopy showed a soft tissue bulge
on its lateral wall.
Based on history and clinical examination, a provisional
diagnosis of antral malignancy was given and differential
diagnosis included squamous cell carcinoma, muco-
epideroid carcinoma, adenoid cystic carcinoma, chondro-
sarcoma and osteosarcoma.
CT scan showed destruction of maxilla on right side,
which was associated with soft tissue replacement
(Figure 1). The lesion was extending into orbit, ethomoid
sinus and pterygopalatine fossa. Incisional biopsy was
taken via sublabial approach. Histopathological findings
were suggestive of a spindle cell malignancy. The
patient then underwent hemimaxillectomy. The tumour
was visualized bulging out from the antrum extending
posteriorly up to pterygoid muscles, superiorly orbital
fat, laterally buccal fat and cheek muscles (not involving
them) and medially eroding the medial wall of maxillary
sinus. Floor of the sinus was found spared.
Histopathologic studies revealed a circumscribed cellular
neoplastic lesion composed of spindle cells arranged in
a storiform pattern. Lesion consisting of fusiform cells
and epithelial cells with marked pleomorphism and
multinucleated giant cells. The diagnosis was sarcoma
of a high grade malignancy. Immunohistochemical
studies showed tumour cells negative for cytokeratines,
actin, desmin, myoglobin and factor VIII, however, it was
positive to Protein S-100 (Figure 2). This led to the final
diagnosis of malignant peripheral nerve sheath tumour
of the maxilla.
The patient was then referred to radiation oncology
service for adjuvant radiation. He is on regular follow-up
for past 8 months and has presented no evidence of
local recurrence. 
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DISCUSSION
MPNST is an aggressive sarcoma of neural origin
showing close association with peripheral nerves
or neurofibroma or may show features of neural
differentiation. Most of these nerve sheath tumours in
nose and paranasal sinuses arise from ophthalmic and
maxillary branches of trigeminal nerve and its branches
although it is difficult to identify exactly which nerve is
involved.4 The most common sites involved are
maxillary and ethmoid sinuses.5
Malignant peripheral nerve sheath tumours can arise de
novo or as a malignant transformation of neuro-
fibromatosis-1 (NF-1) gene. Approximately 50% of
MPNST are associated with a family history of von
Recklinghausen's disease. Since this patient denied of
any such family history it was possibly a de novo case.
The risk of developing MPNST in patients with NF-1 is
approximately 2-4%. It is also seen to arise in patients
previously treated with radiotherapy.6
These cases have been reported in all age groups, but
peek incidence is seen commonly in second and fourth
decade of life with an equal male and female
predilection.7 MPNSTs are commonly seen in lower
extremities and retroperitonium followed by trunk, upper
extremities and head and neck regions. In head and
neck, frequent sites include nasopharynx, paranasal
sinus, nasal cavity, orbit, oral cavity, parapharyngeal
region, neck, thyroid gland and larynx.8,9
The clinical presentations differ as per site involved. But
in case of maxilla, they may present with facial and/or
orbital swelling, paraesthesia of cheek, epiphora, nasal
discharge or epistaxis (if involving nasal cavity). Since
these tumours are aggressive they have tendency to
erode into adjacent bones and tissue. Two third of these
lesions are greater than 5 cm at the time of presentation.
This tumour can spread through hematogenous route
and by perineural extension. Lymph node metastasis is
rare. Roof of orbit and floor of maxilla was not eroded
in this case. However, the anterior wall was deficient
completely. No nodal metastasis was found in this
patient.
Histologically, these tumours have no defined, classic
appearance. Commonly described findings are the
presence of spindle cells with high mitotic rate and
indistinct cytoplasmic borders arranged in bundles or
fascicles. Immunohistochemistry plays an important part
in the diagnosis and in excluding fibrosarcoma, synovial
sarcoma and fibrous histiocytoma. MPNST specifically
demonstrates S-100 positivity.
The recommended treatment of MPNST is the surgical
extirpation including wide margins. In this patient
hemimaxillectomy via Weber-Ferguson incision was
opted. Elective neck dissection is not recommended
unless there is positive radiological and/or clinical
evidence of nodal metastasis. The role of radiotherapy
and chemotherapy is still controversial. This tumour has
been reported radioresistant, but some authors reported
use of complementary radiotherapy.10 However, the
prognosis is poor and even worse in patient with NF-1
disease.
REFERENCES
1. Patil K, Mahima VG, Ambika L. Malignant peripheral nerve
sheath tumour: an elusive diagnosis. Indian J Dent Res 2007; 18:
19-22.
2. Kar M, Deo SV, Shukla NK, Malik A, DattaGupta S, Mohanti BK,
et al. Malignant peripheral nerve sheath tumours (MPNST) -
clinicopathological study and treatment outcome of twenty-four
cases. World J Surg Oncol 2006; 4:55.
3. Lesic A, Bumbasirevic M, Atkinson HD, Maksimovic R, Sopta J,
Atanackovic M. Malignant intraosseous peripheral nerve sheath
tumour of the proximal femur: a case report. J Orthop Surg 2006;
14:84-9.
4. Beegun I, Bottrill ID, Hollowood K. Malignant peripheral nerve
sheath tumours of the infraorbital nerve: case report and
Journal of the College of Physicians and Surgeons Pakistan  2011, Vol. 21 (7): 420-422 421
Malignant peripheral nerve sheath tumour of maxilla
Figure 1:  Pre-operative axial CT shows right maxillary mass.
Figure 2: Patchy immunoreactivity for S-100 protein in the tumour cells
(immunohistochemical stain, 20x).
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